Highlights J. Molner

Equities

MOLNRIPO

EE3100109034

Market Closed - Nasdaq Tallinn Other stock markets 14:30:00 28/06/2024 BST			5-day change	1st Jan Change
14.7 ^EUR	+0.68%		+3.52%	+6.91%

04-30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
03-04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	04-30	CI
J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	03-04	CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US	06/09/23	CI
J. Molner AS has completed an IPO in the amount of Ã‡1.199998 million.	07/11/22	CI
J. Molner AS has filed an IPO in the amount of Ã‡1.199998 million.	12/10/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer